A dysregulated expression of GNL3 has been observed in several cancer cells and it was found to be associated with forced cell growth and survival, increased propensity to metastasize as well as with enhanced resistance to therapies, relapse and poor prognosis [25,26,27,28,29]. This evidence concerns the gene GNL3 and cancer.